Literature DB >> 17326110

Language development and fragile X syndrome: profiles, syndrome-specificity, and within-syndrome differences.

Leonard Abbeduto1, Nancy Brady, Sara T Kover.   

Abstract

Fragile X syndrome (FXS) is the leading inherited cause of mental retardation. In this article, we review what is known about the language and related problems of individuals with FXS. In doing so, we focus on the syndrome-specific features of the language phenotype and on the organismic (i.e., genetic and individual neurocognitive and behavioral) and environmental factors associated with within-syndrome variation in the phenotype. We also briefly review those aspects of the behavioral phenotype of FXS that are relevant for understanding syndrome-specific features of, and within-syndrome variability in, language. The review includes summaries of research on the prelinguistic foundations for language development and on each of the major components of language (i.e., vocabulary, morphosyntax, and pragmatics). Throughout the review, we point out implications of existing research for intervention as well as directions for future research. Copyright 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17326110     DOI: 10.1002/mrdd.20142

Source DB:  PubMed          Journal:  Ment Retard Dev Disabil Res Rev        ISSN: 1080-4013


  88 in total

1.  Expressive language profiles of verbally expressive adolescents and young adults with Down syndrome or fragile X syndrome.

Authors:  Lizbeth H Finestack; Leonard Abbeduto
Journal:  J Speech Lang Hear Res       Date:  2010-07-19       Impact factor: 2.297

2.  Role of maternal gesture use in speech use by children with fragile X syndrome.

Authors:  Laura J Hahn; B Jean Zimmer; Nancy C Brady; Rebecca E Swinburne Romine; Kandace K Fleming
Journal:  Am J Speech Lang Pathol       Date:  2014-05       Impact factor: 2.408

3.  Change in the Behavioral Phenotype of Adolescents and Adults with FXS: Role of the Family Environment.

Authors:  Leann E Smith; Jinkuk Hong; Jan S Greenberg; Marsha R Mailick
Journal:  J Autism Dev Disord       Date:  2016-05

4.  Effect of sustained maternal responsivity on later vocabulary development in children with fragile X syndrome.

Authors:  Nancy Brady; Steven F Warren; Kandace Fleming; Juliana Keller; Audra Sterling
Journal:  J Speech Lang Hear Res       Date:  2014-02       Impact factor: 2.297

5.  Comprehensive motor testing in Fmr1-KO mice exposes temporal defects in oromotor coordination.

Authors:  Snigdha Roy; Yu Zhao; Melody Allensworth; Mohamed F Farook; Mark S LeDoux; Lawrence T Reiter; Detlef H Heck
Journal:  Behav Neurosci       Date:  2011-10-17       Impact factor: 1.912

6.  Longitudinal profiles of expressive vocabulary, syntax and pragmatic language in boys with fragile X syndrome or Down syndrome.

Authors:  Gary E Martin; Molly Losh; Bruno Estigarribia; John Sideris; Joanne Roberts
Journal:  Int J Lang Commun Disord       Date:  2013-04-19       Impact factor: 3.020

7.  Effects of labeling and pointing on object gaze in boys with fragile X syndrome: an eye-tracking study.

Authors:  David P Benjamin; Ann M Mastergeorge; Andrea S McDuffie; Sara T Kover; Randi J Hagerman; Leonard Abbeduto
Journal:  Res Dev Disabil       Date:  2014-07-23

8.  Family environment and behavior problems in children, adolescents, and adults with fragile X syndrome.

Authors:  Jan Greenberg; Marsha Seltzer; Jason Baker; Leann Smith; Steven F Warren; Nancy Brady; Jinkuk Hong
Journal:  Am J Intellect Dev Disabil       Date:  2012-07

9.  Outcome measures for clinical trials in fragile X syndrome.

Authors:  Elizabeth Berry-Kravis; David Hessl; Leonard Abbeduto; Allan L Reiss; Andrea Beckel-Mitchener; Tiina K Urv
Journal:  J Dev Behav Pediatr       Date:  2013-09       Impact factor: 2.225

10.  A Randomized, Double-Blind, Placebo-Controlled Trial of Low-Dose Sertraline in Young Children With Fragile X Syndrome.

Authors:  Laura Greiss Hess; Sarah E Fitzpatrick; Danh V Nguyen; Yanjun Chen; Kimberly N Gaul; Andrea Schneider; Kerrie Lemons Chitwood; Marwa Abd Al Azaim Eldeeb; Jonathan Polussa; David Hessl; Susan Rivera; Randi J Hagerman
Journal:  J Dev Behav Pediatr       Date:  2016-10       Impact factor: 2.225

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.